Quantum BioPharma Ltd.
QNTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,184 | $36,415 | $30,539 | $35,644 |
| - Cash | $5,996 | $2,757 | $16,980 | $35,260 |
| + Debt | $825 | $339 | $516 | $556 |
| Enterprise Value | -$987 | $33,998 | $14,075 | $940 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14,377 | -$15,724 | -$22,117 | -$29,823 |
| % Margin | – | – | – | – |
| Net Income | -$14,203 | -$17,902 | -$23,607 | -$35,285 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.49 | -29.39 | -39.62 | -65.63 |
| % Growth | 57.5% | 25.8% | 39.6% | – |
| Operating Cash Flow | -$6,876 | -$10,827 | -$28,333 | -$20,746 |
| Capital Expenditures | $0 | $0 | -$364 | -$500 |
| Free Cash Flow | -$6,876 | -$10,827 | -$28,697 | -$21,246 |